We found 10 episodes of Radio Advisory with the tag “clinical innovation and affordability”.
-
231: Big deal, little deal, or no deal? A 2024 health policy retrospective
November 19th, 2024 | 40 mins 52 secs
clinical innovation and affordability, physician landscape, provider strategy and financial outlook, value-based care
Drugs, docs, and mandatory payment models. In this episode, host Abby Burns invites Advisory Board experts Gina Lohr, Sarah Roller, and Paul Trigonoplos to unpack three major health policy topics of 2024. The experts explore how these policies are affecting the industry, how the elections outcomes may impact them, and, critically, how much attention leaders need to pay them going forward.
-
230: Elections results are in: What healthcare leaders need to know
November 12th, 2024 | 45 mins 10 secs
clinical innovation and affordability, leadership, provider strategy and financial outlook
The 2024 elections are over. In this episode, hosts Rachel Woods and Abby Burns invite Advisory Board experts Natalie Trebes and Ben Palmer to break down what healthcare leaders can anticipate under incoming federal and state leadership bodies, what impacts new leadership is likely to have on key issue areas like the ACA, Medicaid, drug pricing, abortion, and more, and what we will be watching for in the days, weeks, and months to come. And, of course, what it all means for you, our listeners.
-
229: Live from HLTH: What Can’t GLP-1s Do?
November 5th, 2024 | 41 mins 36 secs
clinical innovation and affordability, external guests, provider strategy and financial outlook
In this episode, recorded live from HLTH 2024, host Rae Woods sits down with Calibrate CEO Rob MacNaughton, Real Chemistry President of Transformative Healthcare Markets Rita Glaze-Rowe, and physician founder, Dr. Spencer Nadolsky, to break down both the optimism and pessimism surrounding GLP-1s, as well as their limitations. In a market that is buzzing around the novel medications, these experts suggest a new focus on comprehensive weight management programs.
-
228: Avoiding ‘pilot purgatory’ in remote patient monitoring
October 29th, 2024 | 23 mins 30 secs
clinical innovation and affordability, provider strategy and financial outlook, tech and ai
In this episode, host Rachel Woods invites Advisory Board experts Lauren Woodrow and Kristin Strubel to unpack the unseen promise of remote patient monitoring (RPM). Together, they explain why most RPM programs aren’t being used to their full potential and share steps leaders can take to optimize their RPM technologies, regardless of what stage of adoption they are in.
-
223: What would it take for home-based care to take off? With Medically Home's Dr. Matt Richards
September 24th, 2024 | 29 mins 55 secs
clinical innovation and affordability, external guests
This week, host Abby Burns invites Dr. Matthew Richards, Senior Medical Director of home-care enablement company Medically Home, to explore the role that home-base care could play in the future of healthcare, and to unpack the misconceptions that prevent home-based care from playing a larger role in the healthcare ecosystem today.
-
222: It's not just GLP-1s; here's what comprehensive weight management looks like
September 10th, 2024 | 25 mins 45 secs
clinical innovation and affordability, service lines
In this episode, host Abby Burns invites Advisory Board experts Chloe Bakst, Payton Grimes, and Atticus Raasch to break down how approaching obesity care holistically can help provider leaders avoid pitting services like bariatric surgery and GLP-1s against each other, and instead compound—rather than cannibalize—the impact each service has on patients, clinicians, and the system as a whole.
-
217: How to make innovation real: Live from Advisory Board's Clinical Innovation Summit
July 23rd, 2024 | 38 mins 32 secs
clinical innovation and affordability, external guests, tech and ai
In this episode, live from Advisory Board's 2024 Clinical Innovation Summit, guest host and Advisory Board digital health expert John League invites Dr. Ayo Ajaiyeoba from Blue Cross Blue Shield of Kansas City, and Elliot Green, cofounder and CEO of Dandelion Health, to share their ideas of what thoughtful, intentional innovation looks like and how to effectively navigate discussions with vendors and payers.
-
213: Radio Advisory Live: Why "value" doesn't have to be zero sum, with Stacey Richter
June 18th, 2024 | 41 mins 25 secs
clinical innovation and affordability, external guests, leadership, value-based care
In this episode, recorded live at Advisory Board’s 2024 Value Summit in New Orleans, host Abby Burns invites Stacey Richter, healthcare entrepreneur, co-president of Aventria Health Group, and host of the Relentless Health Value podcast, to unpack what “value” in healthcare actually means and what it will take to improve value across the industry.
-
211: Pursuing financial sustainability in cell and gene therapy delivery
June 4th, 2024 | 28 mins 41 secs
clinical innovation and affordability, provider strategy and financial outlook
The conversation around cell and gene therapies often centers on payers and purchasers, and the challenge of financing access to these expensive treatments. But there’s a key stakeholder missing from that discussion: the providers. In the final episode of our series on bespoke care and innovation, host Rachel Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to highlight the delivery side of the equation and unpack how providers are grappling with how to get these life-changing treatments to those that need them: patients.
-
210: How you approach precision medicine matters—for some patients more than others
May 28th, 2024 | 31 mins 43 secs
clinical innovation and affordability, health equity
In this episode, host Rachel Woods invites Advisory Board clinical innovation experts Amanda Okaka and Fanta Cherif to break down the health equity conundrum presented by precision medicine: Will precision medicine reduce disparities, or exacerbate them? The answer depends on the actions—big and small—of industry leaders.